AR049915A1 - Compuestos con contenido de boro y metodos de uso de los mismos - Google Patents

Compuestos con contenido de boro y metodos de uso de los mismos

Info

Publication number
AR049915A1
AR049915A1 ARP050102416A ARP050102416A AR049915A1 AR 049915 A1 AR049915 A1 AR 049915A1 AR P050102416 A ARP050102416 A AR P050102416A AR P050102416 A ARP050102416 A AR P050102416A AR 049915 A1 AR049915 A1 AR 049915A1
Authority
AR
Argentina
Prior art keywords
methods
boro
compounds
content
same
Prior art date
Application number
ARP050102416A
Other languages
English (en)
Spanish (es)
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of AR049915A1 publication Critical patent/AR049915A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP050102416A 2004-06-14 2005-06-13 Compuestos con contenido de boro y metodos de uso de los mismos AR049915A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57942104P 2004-06-14 2004-06-14

Publications (1)

Publication Number Publication Date
AR049915A1 true AR049915A1 (es) 2006-09-13

Family

ID=35276660

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102416A AR049915A1 (es) 2004-06-14 2005-06-13 Compuestos con contenido de boro y metodos de uso de los mismos

Country Status (18)

Country Link
US (1) US7652000B2 (enExample)
EP (1) EP1765358B1 (enExample)
JP (1) JP2008502696A (enExample)
KR (1) KR20070043776A (enExample)
CN (1) CN1972695A (enExample)
AR (1) AR049915A1 (enExample)
AT (1) ATE499105T1 (enExample)
AU (1) AU2005254095B2 (enExample)
BR (1) BRPI0512054A (enExample)
CA (1) CA2570477A1 (enExample)
DE (1) DE602005026524D1 (enExample)
IL (1) IL179616A0 (enExample)
MX (1) MXPA06014416A (enExample)
NZ (1) NZ551726A (enExample)
RU (1) RU2007101309A (enExample)
TW (1) TW200612966A (enExample)
WO (1) WO2005123094A2 (enExample)
ZA (1) ZA200610353B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2414906C2 (ru) 2005-02-16 2011-03-27 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы
RU2007139316A (ru) * 2005-03-24 2009-04-27 Анакор Фармасьютикалз, Инк. (Us) Местные композиции антибиотиков бориновой кислоты и способы их использования
CA2635840A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
CN106008571A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
DK1988779T5 (en) 2006-02-16 2016-10-10 Anacor Pharmaceuticals Inc SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS
RU2008152367A (ru) * 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
CN102014927A (zh) 2008-03-06 2011-04-13 安纳考尔医药公司 作为抗炎药的含硼的小分子
US8853424B2 (en) * 2008-08-11 2014-10-07 Japan Science And Technology Agency Protein cross-linking inhibitor
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
TW201109022A (en) 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
WO2011019618A1 (en) * 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060199A1 (en) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
CN108610356B (zh) 2010-09-07 2021-02-26 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
CA2899317C (en) 2013-01-30 2024-09-10 Agrofresh Inc. USE OF BENZOXABOROLES AS VOLATILE ANTIMICROBIAL AGENTS ON MEAT, PLANTS, OR PARTS OF PLANTS
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
AU2016282382A1 (en) * 2015-06-24 2018-02-15 Oriel Seasalt Company Limited A highly concentrated seawater mineral extract and uses thereof
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1233772A4 (en) * 1999-11-19 2004-06-16 Topgene Inc Boron compounds and complexes as anti-inflammatories
CN101928295A (zh) * 2002-12-18 2010-12-29 安那卡药品公司 含有烃基硼酸络合物的抗生素和使用方法

Also Published As

Publication number Publication date
ZA200610353B (en) 2010-07-28
TW200612966A (en) 2006-05-01
RU2007101309A (ru) 2008-07-20
AU2005254095B2 (en) 2010-06-03
CN1972695A (zh) 2007-05-30
WO2005123094A2 (en) 2005-12-29
EP1765358B1 (en) 2011-02-23
BRPI0512054A (pt) 2008-02-06
DE602005026524D1 (de) 2011-04-07
MXPA06014416A (es) 2007-03-08
JP2008502696A (ja) 2008-01-31
EP1765358A2 (en) 2007-03-28
AU2005254095A1 (en) 2005-12-29
CA2570477A1 (en) 2005-12-29
KR20070043776A (ko) 2007-04-25
US7652000B2 (en) 2010-01-26
WO2005123094A3 (en) 2006-02-23
IL179616A0 (en) 2007-05-15
ATE499105T1 (de) 2011-03-15
US20060009422A1 (en) 2006-01-12
NZ551726A (en) 2010-09-30

Similar Documents

Publication Publication Date Title
AR049915A1 (es) Compuestos con contenido de boro y metodos de uso de los mismos
ZA201903125B (en) 7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant idh1 and idh2 inhibitors
CL2007002856A1 (es) Compuestos derivados de pirazolo(1,5)pirimidina; composicion farmaceutica qu lo comprende;y su uso para tratar el cancer.
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
NO20080442L (no) Fosforamidat alkylator promedikament
CL2007001995A1 (es) Compuestos derivados de pirrolotriazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el cancer.
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
TW200740956A (en) Organic electroluminescent devices
ECSP10010559A (es) Compuestos heterociclicos novedosos y usos de los mismos
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
CL2008001633A1 (es) Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
CL2012002844A1 (es) Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende; y su uso en el tratamiento de un trastorno proliferativo de celulas tal como cancer (divisional solicitud nº 311-07).
CL2008001533A1 (es) Formulacion que comprende triazinonas y compuestos o complejos ferricos, utiles para preparar medicamentos para uso veterinario contra la coccidiosis y deficiencias de hierro.
AR050616A1 (es) Composiciones farmaceuticas para el tratamiento de trastornos hiperproliferativos.
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
AR037771A1 (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal
CL2008003265A1 (es) Compuestos derivados de heterociclos nitrogenados, supresores de la produccion de colageno; composicion farmaceutica que comprende dichos compuestos; y su uso para prevenir y/o tratar la fibrosis y/o los tumores.
ATE484508T1 (de) Furylverbindungen
BRPI0606379A2 (pt) triazolftalazinas
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
CL2009000512A1 (es) Compuestos heterociclicos sustituidos derivados de imidazo[4,5-d]piridazina, imidazo[4,5-c]piridazina, imidazo[4,5d]pirimidina, entre otros; composicion farmaceutica que comprende a dichos comppuestos; y uso para tratar el virus de la hepatitis c.
MY158428A (en) Topical composition for the treatment of actinic keratosis
DOP2006000268A (es) Agentes antibacterianos

Legal Events

Date Code Title Description
FB Suspension of granting procedure